Can-Fite BioPharma Ltd Sustainability Reports
Can-Fite BioPharma Ltd. is a clinical-stage biopharmaceutical company that develops orally bioavailable small molecule therapeutic products. Its platform focuses on targeting the A3 adenosine receptor for the treatment of cancer, liver, and inflammatory diseases.
Sector: Manufacturing
Country: Israel
Exchange: Tel Aviv Stock Exchange
LEI: 549300ZLRH6GSBOHFZ59
FIGI: BBG001SPW6H4
1 reports from 2025 to 2025
